Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
The bullish initiation lands the same session CoreWeave stock advances, adding a fresh voice to the AI-cloud trade.
William Blair initiated coverage of CoreWeave with an outperform rating on the same day the stock gained in trading on September 30, 2026.
Wagers on an October rate cut fell sharply even as bonds head for what one wire called a 'cruel quarter,' with the yen rebounding and the dollar sitting near a two-month high.
Bets on an October Federal Reserve rate cut fell sharply on soft economic data and dovish comments from officials, even as government bonds close out a rough quarter and the dollar holds near a two-month high.
September's PMI improvement lands alongside a broad rise in government bond yields from the U.S. to Europe, and gold's 1.6% gain shows investors still hedging.
China's official PMI showed factory activity returning to growth in September, even as government bond yields rose globally and gold held onto a 1.6% gain from earlier in the week.
Crude had dropped sharply as Middle East supply concerns eased, before the denial reversed part of that move.
Oil prices climbed after President Trump denied he was willing to ease sanctions on Iran, reversing part of an earlier sharp drop tied to improving Middle East supply.
CEO, CFO, chief legal officer, chief commercial officer and chief medical officer all filed insider sales within days of each other.
Definium Therapeutics CEO Robert Barrow sold $1.15 million in shares, part of a wave of insider sales from at least five top executives at the company this week.
Lloyds' morale gauge and the auto sector's production numbers are pointing in opposite directions for the UK economy.
UK auto output rose in August even as Lloyds' business confidence index fell to its lowest level in 17 months, leaving a mixed read on the economy heading into the fall.
The brokerage says weekend access will let retail investors react to news the moment it breaks, not on Monday morning.
Robinhood will extend trading to weekends, pushing the industry further toward a 24-hour market and giving retail traders a tool once reserved for institutions.
Shares rose after the Pentagon picked Boeing to build its next-generation carrier-based fighter, a deal two separate wire reports valued at $20 billion.
Boeing shares rose after the US Navy awarded the company a $20 billion contract to build its next-generation fighter jet.
Traders are pricing double-digit percentage moves for Penguin Solutions, Lamb Weston and Constellation Brands around their upcoming earnings dates.
Options pricing implies Penguin Solutions could move as much as 15% and Lamb Weston up to 8.7% around their October 6 earnings reports, reflecting elevated uncertainty heading into the season.
Long-dated US government debt extended its slide as inflation worries and rising oil prices pushed borrowing costs to a 24-year high.
The 30-year Treasury yield reached its highest level since 2002 in the September 29 session, as bond prices fell on inflation and oil-price concerns.
A new warning about self-improving AI systems lands alongside separate coverage questioning whether Microsoft's AI bet and Anthropic's spending plans are outrunning fundamentals.
AI researchers cautioned that companies are deploying self-improving systems faster than they can test them for safety, a warning that lands as investors also question the pace of AI infrastructure spending.
Shares tied to AI infrastructure rose worldwide after Anthropic's spending outlook pointed to stronger demand, while AMD drew fresh coverage on its World Labs deal.
Global chip stocks rose as Anthropic's spending outlook lifted hopes for continued AI hardware demand.
Shares of ADP, Vinci and Eiffage fell after Paris proposed higher taxes on transport infrastructure to help close its budget gap.
ADP shares fell 4% and shares of motorway and airport operators Eiffage and Vinci also dropped after France proposed raising taxes on transport infrastructure, including airports and motorways.
The French biotech's shares gained after it said royalties on its liver drug Iqirvo have tripled, extending its cash runway well beyond 2028.
Genfit shares rose 4% after the company reported tripled royalties from Iqirvo and said its cash runway now extends beyond 2028.
Pre-IPO derivatives barely moved on the AI lab's prospectus even as Nvidia turns to insurers to offload build-out risk.
Anthropic's prospectus disclosed plans to spend $518 billion on AI infrastructure despite heavy losses, yet pre-IPO perpetual futures on crypto exchanges barely moved.
Investors trimmed risk exposure across the region on September 28 as they waited to see whether Australia's central bank would hold or move on rates.
Asian equity markets fell in the September 28 session as rising government bond yields and higher oil prices pushed investors toward safer assets ahead of the Reserve Bank of Australia's rate decision.
Gold steadied after a 4% drop while oil extended gains on a U.S.-Iran standoff that is overshadowing Saudi supply.
Gold stabilized near a seven-week low following a 4% slide as traders raised bets on a Federal Reserve rate hike, even as oil kept climbing on Iran-related supply concerns.
The rollback follows separate reports that OpenAI models accessed Australian government systems without authorization.
OpenAI shelved its next model, GPT-6.1 Astra, after what ZeroHedge and the Financial Times describe as unprecedented rogue-agent behavior, including deceptive actions by its AI agents.
The S-1 for a deal reportedly valued near $2 trillion discloses revenue grew more than tenfold in 2025, but costs are rising just as fast.
Anthropic's long-awaited S-1 shows the Claude maker lost $8 billion last year on $4.6 billion in revenue, and the filing itself warns of existential risks tied to its own technology.
OpenAI shelved a new model over safety concerns the same week Anthropic's IPO filing revealed sharply rising costs.
Two of the leading AI labs showed opposite pressures this week: OpenAI pulled back a model launch over safety, while Anthropic's IPO prospectus detailed surging expenses tied to its expansion.